Vickerstaff, V;
Ambler, G;
Bunce, C;
Xing, W;
Gazzard, G;
(2015)
Statistical analysis plan for the Laser-1st versus Drops-1st for Glaucoma and Ocular Hypertension Trial (LiGHT): a multi-centre randomised controlled trial.
Trials
, 16
(1)
, Article 517. 10.1186/s13063-015-1047-9.
Preview |
Text
Bunce_statistical_analysis.pdf Download (398kB) | Preview |
Abstract
The LiGHT trial (Laser-1st versus Drops-1st for Glaucoma and Ocular Hypertension Trial) is a multicentre randomised controlled trial of two treatment pathways for patients who are newly diagnosed with open-angle glaucoma (OAG) and ocular hypertension (OHT). The main hypothesis for the trial is that lowering intraocular pressure (IOP) with selective laser trabeculoplasty (SLT) as the primary treatment ('Laser-1st') leads to a better health-related quality of life than for those started on IOP-lowering drops as their primary treatment ('Medicine-1st') and that this is associated with reduced costs and improved tolerability of treatment. This paper describes the statistical analysis plan for the study.
Archive Staff Only
View Item |